The Medical Clinics of North America 2001: Vol 85 Index

41 Pages·2001·8.7 MB·English

CUMULATIVE INDEX 2001
Volume 85
ANTIBIOTIC THERAPY, PART II, pages 1-192
January
CARDIAC ARRHYTHMIAS, pages 193-557
March
May ADVANCES IN THE PATHOPHYSIOLOGY AND TREATMENT
OF PSYCHIATRIC DISORDERS: IMPLICATIONS FOR
INTERNAL MEDICINE, pages 559-845
July HEADACHES, pages 847-1099
September POSTOPERATIVE MEDICAI COMPLICATIONS, ppaasg e
November RESPIRATORY INFECTIONS, pages 1329-1634
1umbers of article titles are in boldface type
Abciximab, postoperative bleeding due to detection of
1282 prevention of
Abdominal infections, treatment of, 121 treatment of
in elderly persons, 143 \daptive immunity, in respiratory
Abdominal surgery, postoperative infection defense, 1335-134(
pulmonary complications in Adenocarcinoma, disseminated
1131-1132 intravascular coagulation in
Abortion, septic, disseminated 1292-1293
intravascular coagulation in, 1292 Adenosine
Acamprosate, for alcohol abuse, 787 for paroxysmal supraventricular tachy
Accessory pathways, atrioventricular node cardia, 1179
reentrant tachycardia involving, for supraventricular tachycardia, 212
197-204 . 216
Acetaminophen, for headache, in pediatric for wide QRS complex tachycardia, 262
patients, 1042-1043 264
l-Acetyl-a-methadol (LAAM), for opioid ADHD. See Attention deficit /hyperactivit
abuse, 789 disorder
Acetylcholine deficiency, in delirium, 1230 Adjustment disorders, versus depression
Acid-base imbalance, in postoperative 633-634
kidney dysfunction, 1249 Adolescent Drinking Inventory, 589
Acinetobacter pneumonia, nosocomial, Adrenal gland. See Hypothalamic-
93-94, 1585 pituitary-adrenal axis
Acquired immunodeficiency syndrome. Sec Adrenocorticotropin, stimulation of, in
Human immunodeficiency virus hypothalamic-pituitary-adrenal axis
infection testing, 1314-1315
Actinomycosis, pulmonary Affect, inappropriate, in schizophrenia 666
nonresolving, 1517 Afterdepolarization
radiology of, 1487 delayed, in ventricular tachycardia, 270
Acupuncture, for headache, 1078-1079 early, in polymorphic ventricular tachy-
Acute tubular necrosis, postoperative cardia, 328-329
assessment of, 1246-1249 Agammaglobulinemia, pneumonia risk in,
causes of, 1242-1244 1341
1596 CUMULATIVE INDEX 2001
AIDS. See Human immunodeficiency virus neurologic side effects of, 161
infection. American Academy of Neurology,
Alcohol use and abuse, 783- 1191-1212 migraine practice guidelines of, 873
clinical features of, 590 American College of Cardiology, pacing
consequences of, 784-785 guidelines of, 369-374
definition of, 1191-1193 American Heart Association, pacing
diagnosis of, 587-591 guidelines of, 369-374
emergency presentation of, 784 American Thoracic Society
epidemiology of, 1193-1194 pneumonia prediction rules and practice
headache due to, 925-926 guidelines of, 1400-1401, 1495,
in bipolar disorder, 654 1499-1501
pathophysiology of, 783
pneumonia severity criteria of, 1419
pneumonia risk in, 1341-1342 1420
postoperative withdrawal syndrome in
American trypanosomiasis (Chagas
clinical features of, 1200-1202
disease), ventricular tachycardia in,
delirium tremens in, 1202
299
differential diagnosis of, 1197-1198
Amikacin, for nosocomial pneumonia, 102
early uncomplicated, 1200
Aminoglycosides
hallucinosis in, 1201
physiology of, 1199 for elderly persons, 141
prolonged, 1202 for Pse udomonas aeruginosa infections,
seizures in, 1200 36-38
sequelae of, 1202-1203 resistance to, 21 23,3 , 3167-53 7
severity of, 1200 nephrotoxicity of, 17
time course for, 1199 neurologic side effects of, 161
treatment of, 1203-1207 Amiodarone
preoperative instructions in, 1197 for arrhythmias, perioperative, 1175
prevention of, 1194-1197 1176
relapse from, 786-787 for atrial fibrillation, 234-235
screening for, 1194-1196 for supraventricular tachycardia, 214,
treatment of, 785-787 217
withdrawal from, 783-786 for ventricular tachycardia
Allergic granulomatous angiitis, versus in elderly persons, 542
pneumonia, 1523 in ischemic heart disease, 27
Almotriptan 280-283
for migraine, 962, 963 polymorphic, 331
structure of, 955 for wide QRS complex tachycardia, 263
Alopecia, antibiotic-induced, 179 264
Alprazolam long-term use of, perioperative recom
for generalized anxiety disorder, 705
mendations for, 1120
for social anxiety disorder, 722
Alternative therapies, for headache proarrhythmia monitoring and, 520
pulmonary infiltration due to, versus
1077-1084
acupuncture, 1078-1079 pneumonia, 1524-1525
herbal, 1081-1082 ventricular proarrhythmia due to,
mind-body techniques in, 1079-1080 Amitriptyline, for migraine
nutritional, 1080-1081 in pediatric patients, 1049
with behavioral treatment, 1066
physical approaches to, 1082
Alveolar hemorrhage, in systemic lupus Amnesia, in alcoholism, 785
erythematosus, versus pneumonia Amniotic fluid embolism, disseminated
1423 intravascular coagulation in, 1292
Alveolar macrophages, in respiratory Amoxicillin
infection defense, 1333-1335, 1445 for Helicobacter pylori infections, 120
Alzheimer’s disease, 803-817 for pneumonia, Streptococcus pneumoniae
depression in, 809-810 1374-1375
psychosis in, 810-813 Amoxicillin-clavulanate, for staphylococcal
treatment of, 805-808 infections, 6
versus dementia with Lewy bodies, 804, Amphetamines, abuse of, 780-783
813 Amphotericin B, hypotension due to, 163
Amantadine Ampicillin
for influenza prophylaxis, 1454, 1539 for animal bite infections, 119
1541 for listeriosis, 123
CUMULATIVE INDEX 2001
for pneumonia, Streptococcus pneumoniae for elderly persons, 133-147
1374-1376 for gastrointestinal infections, 120
Amygdala, dysfunction of, in anxiety for osteomyelitis, 117-118
disorders, 569-570 for pneumonia
b-Amyloid deposition, in Alzheimer’s community-acquired, 43-78
disease, 808 guidelines for, 1501-1506
Anaerobic infections switch therapy in, 1429-1434
clindamycin for, 128 nosocomial, 79-113
metronidazole for, 129 ventilator-associated
pneumonia, 1585 inappropriate, 1566, 1571-1572
community-acquired, 53 resistance and, 1566-1567
nosocomial, 95-97 withholding pending culture re
radiology of, 1467 sults, 1569-1570
Analgesics, overuse and misuse of, in for pseudomonal infections, 19-42
headache, 1058-1060, 1067-1068 for sinopulmonary infections, 116-117
Anaphylactic reactions, antibiotic-induced for skin infections, 118-120, 142-143
157, 159 for staphylococcal infections, 1-17
Anemia, antibiotic-induced, 152, 154-155 for urinary tract infections, 123, 142
Anesthesia new uses for, 125-132
anticoagulation and, 1113-1114 nosocomial pneumonia assoc iated with
pulmonary complications due to, 1132 1554
Aneurysm, cerebral oral, 115-123
headache in, 873-878 switching from intravenous the rapy
emergency department handling of, 70, 1429-1434
976-977 resistance to, 115-116
postoperative stroke in, 1271 in pneumonia
Angina pectoris, headache in, 1088-1089 community-acquired, 58-59
Angiography, in headache, 878 1osocomial, 1589-1590
Angioplasty, coronary, before noncardiac ventilator-associated, 1566
surgery, 1159 Pseudomonas aeruginosa, 19-40
Angiotensin-converting enzyme inhibitors staphylococci, 3-5, 10, 127
for congestive heart failure, 1164-1166 Staapp”n hyulko cocc) l
for hypertension, 1154 Strept FOCOCCI pie tae, 1367-1379,
for myocardial infarction, 1160 1503-1504
for ventricular tachycardia, in ischemic side effects of, 149-185
heart disease, 272 cardiac, 163, 169
long-term use of, perioperative recom class, 149-150
mendations for, 1121-1122 gastrointestinal, 170-172
Angiotensin II receptor blockers, long-term hematologic, 150-155
use of, perioperative hepatic, 171, 173-174
recommendations for, 1121-1122 hypersensitivity, 153 156-160
Annexin, antibodies to, bleeding in, in pneumonia, 60 63
1283-1284 individual, 149-150
Antacids, nosocomial pneumonia metabolic, 175, 177-178
associated with, 1553-1554 nephrote X1€ 173, 175-176
Anthrax, treatment of, 118 neurologic, 160 2, 164
Antianginal drugs, long-term use of pulmonary, 162-163, 168
perioperative re¢ ommendations for, Antibody(ies), heparin, thrombocytopenia
1120 due to, 1283-1284, 1289, 1305-1307
Antiarrhythmic drugs. See also specifi ic Anticoagulants
drugs for atrial fibrillation, 231
long-term use of, perioperative recom- for stroke, 1272-1273
mendations for, 1120-1121 perioperative, 1109-1116
proarrhythmia due to. S¢ Proarrhyth- anesthesia safety and, 1113-1114
mia. bleeding risks and, 1109-1110, 1282
Antibiotics. See also specif 1¢ antibioltot ics and l 1286
discontinuation of, thrombosis risks
infec tions
costs of in, 1111-1112
for elderly persons, 135 pharmacokinetics of, 1112-1113
in pneumonia, 64, 66-69 recommendations for, 1114-1115
1598 CUMULATIVE INDEX 2001
Anticoagulants (Continued course of, 701
stroke due to, 1270 definition of, 585
Antidepressants diagnosis of, 586
action of, 563-564 epidemiology of, 692, 694-697
for attention deficit/hyperactivity disor- imaging in, 700
der, 768-769 impairment in, 702-703
for bipolar disorder, 657 pathophysiology of, 697-700
for depression, 564, 635-639, 809-810 risk factors for, 695-696
for generalized anxiety disorder, 705 treatment of, 703-706
for migraine imaging in, 567-569
in pediatric patients, 1049-1050 in medical illness, 586-587
with behavioral treatment, 1066 pathophysiology of, 564-570
for social anxiety disorder, 723-724 social. See Social anxiety disorder.
long-term use of, perioperative recom treatment of, 569-570
mendations for, 1125 underdetection of, 586
Antidiuretic hormone, inappropriate versus attention deficit/hyperactivity
secretion of, postoperative, 1247-1248 disorder, 761-762
Antidromic atrioventricular node reentrant versus normal anxiety, 586
tachycardia, 197 Aplastic anemia, antibiotic-induced, 152
Antiepileptics, long-term use of, 155
perioperative recommendations for, \protinin, for postoperative bleeding,
1124 1287-1288
Antifungal agents, for elderly persons, 144 Ardeparin, for deep vein thrombosis
Antigen recognition and processing, in prevention, 1104
respiratory infection defense, 1336 Argatroban, for heparin-induced
Antigen studies, for pneumonia diagnosis, thrombocytopenia, 1284, 1305-1306
387-1388 Aromatherapy, for headache, 1081
Antihypertensives, long-term use of Arrhythmia(s). See also specific arrhythmias
perioperative recommendations for, antibiotic-induced, 163, 169
1121-1122 implantable cardiac defibrillators for. See
Antikindling agents, for alcohol Implantable cardiac defibrillators.
withdrawal, 785-786 perioperative, 1171-1189
Antioxidants, for Alzheimer’s disease, 807 atrial flutter and atrial fibrillation,
Antiparkinson drugs, 1125 1173-1178
Antipsychotic agents atrial premature contractions, 1176
for Alzheimer’s disease, 810-813 bradycardia, 1172-1173
for bipolar disorder, 655-656, 658 in cardiac surgery, 1173-1174
for schizophrenia, 674-676 in thoracic surgery, 1174-1175
long-term use of, perioperative recom incidence of, 1171-1172
mendations for, 1126 multifocal atrial tachycardia, 1179
Antiretroviral agents, gastrointestinal side 1180
effects of, 170 narrow-complex tachycardia, 1178
Antisocial personality disorder, 828-829 1179
Antithrombin III deficiency, postoperative paroxysmal supraventricular tachycar-
stroke in, 1266 dia, 1178-1179
Antithyroid drugs, long-term use of, risk factors for, 1172-1176
perioperative recommendations for, significance of, 1171-1172
1125 sinus tachycardia, 1172, 1176
Antiviral agents, for elderly persons, 144 ventricular fibrillation, 1180-1181
Anxiety disorder, syncope in, 441-442 ventricular premature contractions
Anxiety disorders 1180
classification of, 585-586 ventricular tachycardia, 1180-1181
depression with, 633 wide-complex tachycardia, 1181
diagnosis of, 584-587 Arrhythmogenic right ventricular
economic impact of, 584 dysplasia, tachycardia in, 296-298
generalized, 691-710 Arteriovenous malformations, versus
clinical features of, 701 migraine, 872-873
comorbidity with, 696-697, 702 Arteritis, giant cell (temporal), headache
concept of, 691-693 in, 879-882, 980, 1087-1088
costs of, 702-703 Arthropathy, antibiotic-induced, 177, 179
CUMULATIVE INDEX 2001 1599
Arthroplasty, thrombosis prophylaxis after, catheter ablation, 479-484
1101-1107 nonpharmacologic, 235-238
Aspartame, as migraine trigger, 931 pacemaker, 236, 239, 386-389
Aspergillosis, pulmonary pharmacologic, 233-234
nonresolving, 1516 sinus rhythm restoration and mainte
nosocomial, 1586 nance in, 231-239
radiology of, 1485-1487 thromboembolic prophylaxis in, 231
Aspiration, for pneumonia diagnosis vagally mediated, pacemaker in, 386-389
transthoracic, 1390-1391 Atrial premature beats
transtracheal, 1389-1390 in elderly persons, 527-529
Aspiration pneumonia perioperative, 1176
in elderly persons, 1444 Atrial tachycardia, 201, 20
treatment of, 53 as proarrhythmia, 511 5
versus community-acquired pneumonia, catheter ablation of, 47
1525
foc al 478
Aspirin in elderly persons, 5
for atrial fibrillation, 231, 531-532
incisional, 479
for myocardial infarction, 1160 multifocal, 206, 208
for stroke, 1273 perioperative, 1179-1180
prophylactic, in carotid endarterec- pacemaker in, 399-400
tomy, 1268
Atrioventricular block
long-term use of, perioperative recom- in elderly persons, 533-534
mendations for, 1119 pacemaker in, 370, 390-400
postoperative bleeding due to, 1281
perioperative 1181-1182
Asthma, drugs for, long-term use of,
Atrioventricular dissociation, in
perioperative recommendations for,
tachycardia, 253-255
1122-1123
Atrioventricular junction, catheter ablation
Ataxia, cerebellar, antibiotic-induced, 165 of, 490-491
Atenolol
Atrioventricular node reentran
for alcohol withdrawal, 1206
for myocardial ischemia prevention tachycardia, 194-197
1157 catheter ablation of 484-486, 489-490
mediated by accessory pathways, 197
for social anxiety disorder, 722
204
for supraventricular tachycardia, 214
Atrium, remodeling of, in atrial
216
fibrillation, 229, 238-239
for syncope, 448
Atherosclerosis Attention deficit, in delirium, 1231
in diabetes mellitus, postoperative con- Attention deficit/hyperactivity disorder
siderations in, 1216-1217 CeiTte dh ed- ed|ad
classification of, 759-760
myocardial ischemia in, perioperative,
clinical features of, 759
1155
Atrial tibrillation and atrial flutter, 225-244 comorbidity with, 762
differential diagnosis of, 761
anticoagulant therapy for, perioperative
epidemiology of, 758-759
recommendations for, 1111-1112
begets atrial fibrillation, 229 evaluation of, 761
causes of, 225-227 historical overview of, 75
chronic, 227, 484 medical illness with, 762
clinical assessment of, 229-230 psychiatric interview in, 7
epidemiology of, 225-227 psychologic testing in, 7
in elderly persons, 529-532 rating scales for, 763-764
in Wolff-Parkinson-White syndrome, Tourette syndrome with, 744
199, 218-219 treatment of, 766-773
natural history of, 227-228 behavioral, 771-7
paroxysmal, 227, 483 in adults, 772-773
pathophysiology of, 228-229 pharmacologic, 766 |
perioperative, 1173-1178 Atypical pneumonia syndrome, 1349-1365
stroke in, 1264-1265 See also spec Ifl¢ pathoger S
persistent, 227 clinical features of
treatment of, 230-239 coinfections 1n, l 35-
atrial remodeling prevention in, 238 diagnosis of, 135¢ >
239 epidemiology of
1600 CUMULATIVE INDEX 2001
Atypical pneumonia syndrome (Continued J) analgesic overuse control in, 1067
historical perspective of, 1350-1351 1068
nonresolving, 1514 analgesic use evaluation for, 1058
prognosis for, 1358-13 59 1060
treatment of, 1358-1359, 1502-1503 biofeedback in, 1063-1065
unknown pathogens in, 1354 chronic daily, 1058-1059, 1064
AUDIT questionnaire, for alcohol use cognitive-behavioral analysis for, 1056
screening, 1194-1196 comorbid psychiatric disorder evalua-
Aura tion for, 1061-1063
migraine with, 898-901, 945, 948 compliance issues in, 1069-107 0
migraine without, 898-901, 951 disability impact evaluation for, 1063
versus tension-type headache, 903-906 factors underlying, 1068-1069
Automatic information processing, in future of, 1070-1071
obsessive-compulsive disorder, 740 in multidisciplinary, 1068
Automaticity, of pacemakers, 404-406 migraine, 1063-1067
Autonomic dysfunction multiaxial behavioral assessment for
in anxiety disorders, 699-701 1057-1063
in cluster headache, 998-999 pharmacotherapy with, 1065-1067
in SUNCT syndrome, 1007 posttraumatic, 1065
syncope In. 5ee Syncope, in autonomic relaxation therapy in, 1063-1065
dysfunction stress assessment for, 1060
Avoidant personality disorder, 829 tension-type 1065-1067
Azithromycin for psychiatric disorde|r s, 619
for elderly persons, 139 for social anxiety disorder, 724
for pneumonia, 69 Behavioral triggers, of migraine, 912
918-920
community-acquired, 1505
AzlociSltlrien,p tocfoorc cuPss epundeoummoonnaisa Benfozro dailaczoehpoli new(ist)h drawal, 785 1205-121 206
infections, 20-21, 25 for delirium, 1236
Azotemia, in postoperative kidney for generalized anxiety disorder
dysfunction, 1248 for social anxiety disorder, 722
Aztreonam long-term use of perioperative recom
for elderly persons 138 mendations for, 1126
for nosocomial pneumonia, 102 Benzodiazepine complex, abnormalities
for Pseudomonas aeruginosa infections in anxiety disorders, 698
pharmacokinetics of, 24 Benztropine mesylate, for migraine, 982
resistance to, 2 1-22 Bereavement, versus depression, 633
Beta-blockers
for alcohol withdrawal, 1206
for atrial fibrillation, 1174
B lymphocytes, in respiratory infection for congestive heart failure, 1165
defense, 1331-1332, 1339-1340 for hypertension, 1154
Bacitracin, for skin infections, 118 for long Q-T syndrome, 336
Bacteroides pneumonia for migraine, 956, 1050-1051
community-acquired, 5 -] for myocardial infarction, 1160
nosocomia!, 95-96 for myocardial ischemia prevention,
Barbiturates, for alcohol withdrawal 1157, 1159
1206-1207 for social anxiety disorder, 723
Basal ganglia, pathology of, in for supraventricular tachycardia, 214
schizophrenia, 671-672 217
Basilar artery migraine, 907 for syncope, 469
BATHE mnemonic, for anxiety screening, for ventricular tachycardia, in elderly
703 persons, 541-542
Behavioral therapy long-term use of, perioperative recom-
for alcohol abuse, 1204 mendations for, 1120-1121
for attention deficit/hyperactivity disor Beta-lactam antibiotics. See also
der, 771-773 Penicillin(s); specific antibiotics
for headache, 1055-1075 anaphylactic reactions to, 157
activity participation in, 1069 for elderly persons, 136-138
advantages of, 1055-1056 for Staphylococcus aureus infections, 5-7
CUMULATIVE INDEX 2001 1601
nephrotoxicity of, 175 risks of, in surgical procedures, anticoag
resistance to, 2 3, 10 ulation and 1109-1110, 1114
Beta-lactamase inhibitors, for elderly Blindness, antibiotic-induced, 162, 167
persons, 138-139 Blood culture, for pneumonia diagnosis
Biapenem, for Pseudomonas aeruginosa 1386, 1449-1450
infections, 30, 33 Blood transfusions, postoperative bleeding
Bifascicular block
related to 1288 1289
pacemaker in, 370 Boils, treatment of, 118
perioperative, 1182 Borderline personality disorder, 825
Biofeedback, for headache, 1063-1065 1062-1063
1079-1080 Bradycardia
Biofilm, antibiotic resistance in, is proarrhythmia, treatment of, 522-523
Staphylococcus epidermidis, 11 drug-induced, 511
Biopsy in elderly persons, 532 935
brain, postoperative stroke in, 1271 pacing for, implantable cardi
lung, in pneumonia, 1391 lator in, 350 351
Bipolar disorder, 635-662 perioperative
causes of, 647 Brain
clinical features of, 647-652 aneurysm of!
depression in, 649-650, 657 headache in
diagnosis of, 652-655 postoperati\
epidemiology of, 646-647
genetics of, 645-646
137
illnesses with, 654-655
mania in, 647-649, 655-656 injury of
mixed episodes in, 650-652 disseming
psychotherapy for,
rapid cycling in
treatment of, 655-658
~
type L, diagnosis of, 652-653 tumors of
type II, diagnosis of, 6 = > headache
versus attention deficit/hyperactiy postoperative
disorder, 761 vasculitis 0
versus schizophrenia, 668
Bisoprolol, for myocardial ischemia
prevention, 1157 stroke In
Bites, animal, treatment of, 119-12 Bretylium, for
Blastomycosis, pulmonar tachycardia
nonresolving, 1515 Brief Social Phobia Scale
radiology of, 1484 disorder, 714, 716
Bleeding. See also Hemorrhage British horacic Society, pneumonia
antibiotic-induced, 152-153, 155 prediction rules and practice
postoperative, 1277-1310 guidelines of, 1400, 1495-1496
anticoagulant-induced, 1282-1288 Brofaromine, for social anxiety disorder
assessment of, 1280-1281 799_792
case studies of, 1298-1308 Bromocriptine
hemostasis physiology and, 1277-1280 for menstrual migraine 1024-1025
in acquired factor VIII inhibitors long term use of perioperative recom
1298-1302 mendations for 1125
in disseminated intravascular coagula- Bronchioalveolar carcinoma, versus
tion, 1290-1296 pneumonia
in fibrinolysis, 1295, 1297 Bronchiolitis obliterans organizing
in heparin therapy, 1302-1307 pneumonia, 1519
in prostatectomy, 1289-1290 Bronchoalveolar lavage, for pneumonia
in thrombocytopenia, 1307-1308 diagnosis, ventilator-associated
platelet inhibitors causing, 1281-1282 1574-1576
transfusion-related, 1288-1289 Bronchopneumonia, radiology of
uremic, 1297 1465-1467
uterine, 1290 Bronchoscopy
wound management in, 1297 for pneumonia diagnosis, 1390-1391
1602 CUMULATIVE INDEX 2001
Bronchoscopy (Continued) Cardiac arrhythmias. See also specifi
ventilator-associated, 1574-1576 arrhythmias
nosocomial pneumonia risk in, 1556 atrial fibrillation. See Atrial fibrillation
Brugada’s syndrome, 294-295, 323-324 and atrial flutter.
Bundle-branch block catheter ablation of. See Catheter abla-
in elderly persons, 534 tion.
in idiopathic cardiomyopathy, ventricu- defibrillators for. See Implantable cardiac
lar tachycardia in, 284-286 defibrillators
wide QRS complex tachycardia in, 258 in elderly persons, 527-550
260-261 pacing for. See Pacemakers
Bupropion proarrhythmia, 503-526
for attention deficit/hyperactivity disor- supraventricular tachycardia. See Supra
der, 766-767, 769 ventricular tachycardia
for depression, 636 syncope in. See Syncope
for smoking cessation, 791 ventricular tachycardia. See Ventricular
Buspirone tachycardia.
for generalized anxiety disorder, 705 wide QRS complex tachycardias, 245-
for social anxiety disorder, 723-724
266
Butorphanol, for cluster headache, 982 Cardiac cephalalgia, 1088-1089
Butterbur root, for headache, 1081
Cardiac risk index, preoperative, 113
Cardiomyopathy
dilated
Caffeine pacemaker in, 297/73
as migraine trigger, 923-925 ventricular tachycardia in
for headache, 1081 495-496
for hypnic headache syndrome, 1009 hypertrophic
pacemaker in, 372, 379-382
1011
CAGE questionnaire, for alcohol use ventricular tachycardia in, 286-288
screening, 589-591, 1194-1196 310-311
Calcium channel blockers, long-term use idiopathic, ventricular tachycardia in,
of, perioperativ e recommendations 284-286
for, 1120-1121 progressive, arrhythmogenic right ven-
Campylobacter gastroenteritis, treatment tricular dysplasia in, 296-298
122 Cardiopulmonary risk index, preoperative,
Canadian guidelines, for community- 1134
acquired pneumonia, 1497-1499 Cardiovascular disease
Cancer antibiotic-induced, 163, 169
disseminated intravascular coagulation drugs for, long-term use of, periopera-
in, 1292-1293 tive recommendations for, 1120-1122
hypercoagulopathy in, postoperative perioperative, 1151-1168. See also Ar-
stroke in, 1267 rhythmia(s), perioperative.
lung, versus pneumonia, 1520-1522 congestive heart failure, 1161-1166
Candida albicans pneumonia, nosocomial, hypertension, 1151-1154
1586 hypotension, 1153, 1155
Carbamazepine myocardial ischemia and myocardial
for alcohol withdrawal, 785-786, 1206 infarction, 1155-1161
for bipolar disorder, 655-658 stroke in, postoperative, 1264-1265
for cranial neuralgia, 983 Cardiovascular surgery. See also Coronary
Carbapenems artery bypass graft surgery.
for elderly persons, 138 arrhythmias related to, 1173-1174
for nosocomial pneumonia, 101-102 postoperative stroke in, 1267-1269
for Pseudomonas aeruginosa infections, Cardioversion
29-33 for atrial fibrillation, 231-233, 1177
for Streptococcus pneumoniae pneumonia, for proarrhythmia, 522
resistance to, 1368 for wide QRS complex tachycardia evalu-
Carbidopa/levodopa, perioperative ation, 263
recommendations for, 1125 Carotid arteries
Carbuncles, treatment of, 118 dissection of, headache in, 977
Cardiac arrest. See also Mortality. endarterectomy of, postoperative stroke
antiarrhythmic agent-induced, 510-511 in, 1267-1269, 1271
CUMULATIVE INDEX 2001
injury of, headache in, 1089-1090 Streptococe us pneumonia 1374 1376
ultrasonography of, in syncope, 437 for Pseudomonas aeruginosa infections, 24
Carotid sinus massage 26-28
for paroxysmal supraventricular tachy- resistance to 22, 26-27
cardia, 1179 for Streptococcus pneumoniae pneumonia
for supraventricular tachycardia, 2 resistance to, 1368-1373
for syncope evaluation, 440-441 gastrointestinal side effects of, 170
Carotid sinus syndrome, pacemaker in, hematologic effects of, 152
372, 390 erebellar ataxia, antibiotic-induced, 165
Carvedilol, for ventricular tachycardia, in erebellar atrophy, syncope in, 463
elderly persons, 541-542 erebritis, headache in, 979
Catecholaminergic polymorphic erebrospinal fluid
ventricular tachycardia, 296, 323, 333 examination of, in headache, 876-8
Catheter ablation, 473-502 hypotension of, headache in, 980
of atrial fibrillation and atrial flutter Cervicogenic headache, 988-989
230, 235-236, 479-484 Cervicothoracic ganglionectomy for long
Q-T syndrome, 336
of atrial tachycardia, 477-479, 529
Chagas’ disease, ventricular tachycardia in
of atrioventricular junction, 490-491
299
of atrioventricular nodal reentrant tachy-
Chemotherapy, pneumonia risk in, 1
cardia, 484-486, 489-490
Chinese restaurant syndrome, 928
of concealed pathway arrhythmias, 484 Chiropractic, for headache, 1082
488 Chlamydia pneumoniae pneumonia,
of preexcitation syndrome arrhythmias
community-acquired, 46, 1349
484-488 clinical features of, 1351
of supraventricular tachycardia, 218, 220 coinfection with, 1354-1356
of ventricular tachycardia diagnosis of, 1357, 1387
bundle-branch reentrant, 493 differential diagnosis of, 48-49
economic considerations in, 496 epidemiology of, 1352-1354
idiopathic, 492-493 nonresolving, 1514
in elderly persons, 543 prognosis for, 1358-1359
nonidiopathic, 493-496 treatment of, 1358 1359, 1502-1503
of Wolff-Parkinson-White syndrome ar- empiric, 53
rhythmias, 484-486 monotherapy versus combination the
procedure for, 474-477 apy in, 63, 65-66
Catheter-related sepsis, in nutritional Chloramphenicol
support, 1260 for Streptococcus pneumoniae pneumonia
Cefazolin, for staphylococcal infections resistance to, 1368
6-7 hematologic effects of, 152
Cefepime, for nosocomial pneumonia, new uses for, 130
101-103 resistance to, 3, 10
Cefoperazone, for Pseudomonas aeruginosa Chlordiazepoxide, for alcohol withdrawal
infections, 24, 26-28 1205
Chloride, fractional excretion of, in
Cefsulodin, for Pseudomonas aeruginosa
postoperative kidney dysfunction
infections, 24, 26-28
Ceftazidime, for Pseudomonas aeruginosa 1246-1247
infections, 24, 26-28 Chlorpromazine, for schizophrenia, 674
Chocolate, as migraine trigger, 926-927
Ceftriaxone, for pneumonia, 69 Cholecystokinin, abnormalitieso f, in
Celecoxib, long-term use of, perioperative anxiety disorders, 567, 699
recommendations for, 1119-1120 Cholera, treatment of, 122
Cellulitis, treatment of, 119 Cholestasis, antibiotic-induced, 173-174
Center for Epidemiological Cholestyramine, long-term use of
Studies—Depression screen, 582-583 perioperative recommendations for
Centers for Disease Control, pneumonia 1122
practice guidelines of, 1497 Cholinesterase inhibitors, for Alzheimer’s
Cephalexin, for skin infections, 118 disease, 805-807
Cephalosporins Chronic granulomatous disease
for elderly persons, 137-138 pneumonia risk in, 1341-1342
for pneumonia Chronic obstructive pulmonary disease,
community -acquired, 66, 69 postoperative pulmonary complication
nosocomial, 96, 99-101 risk in, 1131
1604 CUMULATIVE INDEX 2001
Churg-Strauss syndrome, versus chronic, 998
pneumonia, 1523 epidemiology of, 997
Cigarette smoking, 790-791 episodic, 998
as migraine trigger, 922-923 impact of, 891
in schizophrenia, 679 treatment of, emergency, 982-983
screening for, 591-592 versus hemicrania continua, 1004—1006,
Cimetidine, triptan interactions with, 963 1010
Ciprofloxacin versus hypnic headache syndrome,
for abdominal infections, 121 1009-1011
for pneumonia, community -acquired versus paroxysmal hemicrania, 1000
1504-1505 1004, 1010
for Pseudomonas aeruginosa infections versus SUNCT syndrome, 1006-1008,
21-22, 33-35, 119 1010
for skin infections, 118 luster-migraine syndrome, 1008-1009
for staphylococcal infections, 6 luster-tic syndrome, 1008-1009
for Streptococcus pneumoniae pneumonia oagulation factors, requirements of, for
1368 adequate hemostasis, 1296
minimal inhibitory concentration drift oagulopathy. See also Bleeding,
of, 59 postoperative; Hypercoagulability
neurologic side effects of, 161 Thrombosis
resistance to, 33-34, 1368 antibiotic-induced, 152-153, i155
Citalopram, for depression, 636 anticoagulant therapy for, perioperative
Clarithromycin recommendations for, 1112
for elderly persons, 139 stroke in, 1270
for Helicobacter pylori infections, 120 Cocaine abuse, 780-783
for Streptococcus pneumoniae pneumonia Coccidioidomycosis, pulmonary
374 nonresolving, 1516
gastrointestinal side effects of, 170 radiology of, 1482-1484
Clinafloxacin, for Pseudomonas aeruginosa Cockcroft-Gault formula, for kidney
infections, 35-36 function evaluation, 1245-1246
Clindamycin Cognitive behavior therapy
for skin infections, 118 for generalized anxiety disorder, 703-704
for staphylococcal infections, 6 for obsessive-c ompulsive disorder, 741
for Streptococcus pneumoniae pneumonia for psychiatric disorders, 619-620
1368-1369 Cognitive-behavioral treatment. Se¢
neurologic side effects of, 161 Behavioral therapy
new uses for, 128-129 Cognitive coping strategies, for
resistance to, 10, 1368-1369 schizophrenia, 623
Clinical pathways, for pneumonia care Cognitive dysfunction
1434 in delirium, 1231
Clonazepam, for social anxiety disorder in dementia. See Dementia.
722 in schizophrenia, 666-667
Clonidine Cognitive rehabilitation, for schizophrenia,
for alcohol withdrawal, 1206 623
for attention deficit/hyperactivity disor- Cold therapy, for headache, 1082
der, 767 Colestipol, long-term use of, perioperative
for hypertension, 1154 recommendations for, 1122
for opioid withdrawal, 788 Colonization, of pneumonia organisms, in
for syncope, 470 elderly persons, 1444
for Tourette syndrome, 749 Common variable immunodeficiency,
long-term use of, perioperative recom- pneumonia risk in, 1341
mendations for, 1122 C ommunity-acquired pneumonia. See
withdrawal from, hypertension in, 1152 Pneumonia, community-acquired
Clopidogrel, postoperative bleeding due Complementary therapies. See Alternative
to, 1281-1282 therapies.
Clostridium difficile infections, antibiotic- Computed tomography
induced, 67, 121, 171-172 in headache, 866-867, 870-871, 875-876,
Clozapine, for schizophrenia, 675 878
Cluster headache, 850, 997-1016 in pediatric patients, 1047
aggravating factors for, 855 migraine, 871-872, 902-903